Cassava Sciences Stock is Rallying
Cassava Sciences (SAVA) stock closed on Friday, December 27, 2019 at $5.21, reaching a 52-week high. Today, December 30, 2019 the stock is jumping higher, trading now at $6.40, UP $1.19 despite the underperforming market today.
The reason for investors’ rush to buy the stock is due to the good news from a Phase 2 trial of Cassava’s Alzheimer Disease product PTI-125. The promising data were presented by the firm’s scientists during a late-breaking oral presentation at the 12th International Conference on Clinical Trials on Alzheimer’s Disease (CTAD), in San Diego, Ca.
See the firm’s press release posted under our Impacting News column.